"ACDIMA Center for Bioequivalence and Pharmaceutical Studies (ACDIMA BioCenter) is a Contract Research Organization (CRO) that was established in 2000, for the purpose of providing contracted services for Pharmaceutical Companies. The center is considered as one of the multi projects invested by the Arab Company for Drug Industry and Medical Appliances (ACDIMA) Board of Directors."

During the past decade, ACDIMA Biocenter conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ACDIMA Biocenter" are "Analgesic" (1 trials), "Anthelmintic Agent" (1 trials), "Antipyretic" (1 trials), "Non-steroidal Anti-inflammatory (NSAID)" (1 trials) and "Seasonal Allergic Rhinitis" (1 trials). Many other conditions were trialed in "ACDIMA Biocenter" in a lesser frequency.

Most popular intervention types in "ACDIMA Biocenter" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "140/100 μg Azelastine hydrochloride/Beclomethasone Dipropionate)" (1 trials), "Cataflam® 50 coated tablet" (1 trials), "Diclofenac Potassium coated tablet (50 mg Diclofenac Potassium)" (1 trials), "Ivermectin tablets (3 mg Ivermectin)" (1 trials) and "Stromectol ® tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "ACDIMA Biocenter" are 3 trials for "All" genders.

Currently, there are NaN active trials in "ACDIMA Biocenter". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ACDIMA Biocenter, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ACDIMA Biocenter, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".